Abivax (ABVX) Beginning Cash Balance (2025)
Abivax (ABVX) recorded quarterly Beginning Cash Balance of -$14.8 million in Q2 2025, down 129.08% quarter-over-quarter from -$6.4 million in Q1 2025.
Abivax (ABVX) Beginning Cash Balance (2025) Analysis & Trends
Abivax's Beginning Cash Balance history runs 1 years deep, the most recent figure standing at -$14.8 million for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -14.75 Mn |
| Jun 30, 2025 | -14.75 Mn |
| Mar 31, 2025 | -6.44 Mn |
| Mar 31, 2025 | -6.44 Mn |